These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 25174355)
1. E2F1 downregulation by arsenic trioxide in lung adenocarcinoma. Lam SK; Li YY; Zheng CY; Leung LL; Ho JC Int J Oncol; 2014 Nov; 45(5):2033-43. PubMed ID: 25174355 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma. Lam SK; Li YY; Zheng CY; Ho JC Int J Oncol; 2015 Jan; 46(1):113-22. PubMed ID: 25335113 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma. Lam SK; Mak JC; Zheng CY; Li YY; Kwong YL; Ho JC Int J Oncol; 2014 Jun; 44(6):2093-102. PubMed ID: 24691991 [TBL] [Abstract][Full Text] [Related]
4. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma. Lam SK; Leung LL; Li YY; Zheng CY; Ho JC Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399 [TBL] [Abstract][Full Text] [Related]
5. Combination of arsenic trioxide and chemotherapy in small cell lung cancer. Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618 [TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis. Chen H; Gu S; Dai H; Li X; Zhang Z Biol Trace Elem Res; 2017 Oct; 179(2):203-212. PubMed ID: 28261759 [TBL] [Abstract][Full Text] [Related]
7. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells. Gu S; Chen C; Jiang X; Zhang Z Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155 [TBL] [Abstract][Full Text] [Related]
8. Tumour growth-suppressive effect of arsenic trioxide in squamous cell lung carcinoma. Leung LL; Lam SK; Li YY; Ho JC Oncol Lett; 2017 Sep; 14(3):3748-3754. PubMed ID: 28927142 [TBL] [Abstract][Full Text] [Related]
9. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo. Shen L; Zhang G; Lou Z; Xu G; Zhang G BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727 [TBL] [Abstract][Full Text] [Related]
10. [miR-155/BACH1 Signaling Pathway in Human Lung Adenocarcinoma Cell Death Induced by Arsenic Trioxide]. Gu SY; Chen HY; Dai HM; Li XY; Zhang ZZ Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):828-833. PubMed ID: 29260515 [TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH. Han YH; Kim SZ; Kim SH; Park WH Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383 [TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity. Zheng CY; Lam SK; Li YY; Ho JC Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414 [TBL] [Abstract][Full Text] [Related]
13. The growth-inhibitory and apoptosis-inducing effect of deferoxamine combined with arsenic trioxide on HL-60 xenografts in nude mice. Yu R; Wang D; Ren X; Zeng L; Liu Y Leuk Res; 2014 Sep; 38(9):1085-90. PubMed ID: 24908354 [TBL] [Abstract][Full Text] [Related]
14. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide. Chien CW; Yao JH; Chang SY; Lee PC; Lee TC Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949 [TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide reduces the expression of E2F1, cyclin E, and phosphorylation of PI3K signaling molecules in acute leukemia cells. Kumar S; Tchounwou PB Environ Toxicol; 2021 Sep; 36(9):1785-1792. PubMed ID: 34042274 [TBL] [Abstract][Full Text] [Related]
16. BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine. Tanaka Y; Komatsu T; Shigemi H; Yamauchi T; Fujii Y BMC Cancer; 2014 Jan; 14():27. PubMed ID: 24428916 [TBL] [Abstract][Full Text] [Related]
17. Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cells. Kasukabe T; Okabe-Kado J; Kato N; Honma Y; Kumakura S Int J Oncol; 2015 Feb; 46(2):841-8. PubMed ID: 25405645 [TBL] [Abstract][Full Text] [Related]
18. Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma. Bao X; Ren T; Huang Y; Wang S; Zhang F; Liu K; Zheng B; Guo W J Exp Clin Cancer Res; 2016 Aug; 35(1):129. PubMed ID: 27576314 [TBL] [Abstract][Full Text] [Related]
19. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis. Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143 [TBL] [Abstract][Full Text] [Related]
20. TRIM28 knockdown increases sensitivity to etoposide by upregulating E2F1 in non-small cell lung cancer. Liu L; Xiao L; Liang X; Chen L; Cheng L; Zhang L; Wu X; Xu Q; Ma C Oncol Rep; 2017 Jun; 37(6):3597-3605. PubMed ID: 28498400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]